๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Sulfamates and Their Therapeutic Potential

โœ Scribed by Jean-Yves Winum; Andrea Scozzafava; Jean-Louis Montero; Claudiu T. Supuran


Publisher
John Wiley and Sons
Year
2005
Weight
8 KB
Volume
36
Category
Article
ISSN
0931-7597

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Emerging new chemokine CXCR3 antagonists
โœ Shailendra Kapoor ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 47 KB

hospitalized in urban teaching centers (52% versus 41%; P ฯฝ 0.0001). ALI and liver failure 7 occurred in 8.2% and 4.5% of patients, respectively; 1.4% died. ALI (16.7% versus 8.0%; P ฯฝ 0.0001), liver failure (11.4% versus 4.4%; P ฯฝ 0.0001), and death (3.0% versus 1.4%; P ฯญ 0.01), but not transplanta

Albumin: Biochemical properties and ther
โœ Gregory J. Quinlan; Greg S. Martin; Timothy W. Evans ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 319 KB

Ligand-Binding. HSA binds many endogenous and exogenous compounds, including fatty acids, metal ions, pharmaceuticals, and metabolites, with implications for drug delivery and efficacy, detoxification, and antioxidant protection. Several low-and high-affinity ligand-binding sites have been identifie

Purinergic signalling: Therapeutic poten
โœ Geoffrey Burnstock ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 105 KB

This article begins with a brief review of the current status of receptor subtypes for purines and pyrimidines. It then focuses on pathophysiological roles of ATP and discusses some related therapeutic possibilities. Finally, the expanding field of purinergic signalling in embryology is introduced.